Adelaide University researchers have found a DNA 'switch' that helps the body stop the growth of the most common form of breast cancer, providing new insights that could help with future treatments. Up to 80% of breast cancer cases are classified…
| Newswise Newswise Precision Oncology: The âGenetic Mapâ of Patientâs Tumor Uncovers Cancer Risk Genes That Would Otherwise Remain Hidden These are the findings of an ongoing clinical study at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS. One in…
From 1 December 2026, Singapore Citizens and PRs can get means-tested subsidies of up to 70% on genetic testing for hereditary breast and ovarian cancer (HBOC) at three public cancer clinics. MOH says the roughly $1,000 test can cost $0 out of pocket with enough…
New American Cancer Society (ACS) research reveals a gap between breast cancer awareness and action that can save lives. In Arizona, approximately 900 women died from breast cancer in 2024, according to the latest available ADHS data. Breast Cancer Awareness Month is…
Platinum-based chemotherapy has been used in cancer treatment for decades and remains an important part of care for several common cancers. Cisplatin, carboplatin, and oxaliplatin are the three main drugs in this group. Each has a different role, from treating…
Pertuzumab is approved in combination with trastuzumab and chemotherapy for selected patients with early and metastatic HER2-positive breast cancer. More recently, its clinical role expanded through combination with trastuzumab deruxtecan, which received FDA approval for first-line unresectable or metastatic HER2-positive…
An annual student fundraiser at Lockerby Composite School in Greater Sudbury raised $51,600 in the Kids Caring for Kids Cancer Drive in memory of Laura Cotesta.
The most commonly reported cancer treatment side effects include: Most side effects can be managed with appropriate supportive care, although some may persist or require treatment modifications. Patients should inform their oncology team about new or worsening symptoms rather than…
First approved by the FDA in 1998, trastuzumab transformed the treatment of HER2-positive breast cancer, a subtype historically associated with aggressive disease and poor outcomes. It subsequently became an established treatment for HER2-positive metastatic gastric and gastroesophageal junction (GEJ) adenocarcinoma. Trastuzumab…
Radiotherapy uses high-energy radiation to damage the DNA of cancer cells, preventing their continued growth and division. Unlike systemic treatments such as chemotherapy, radiotherapy primarily targets a defined area of the body. Radiotherapy can also be classified according to its…
Screening, genetics, surgical/medical treatment, and survivorship supports.
An article joins this feed when it matches these terms. Each one is also a search of its own.